26bd8dachangelog v2.16.1 is 6 commits behind this build β last written 8d ago, so 6 changes to what the site shows are unrecorded
π Session report
Posted unattended (--auto); not yet reviewed by @jwildfire.
#35 advanced through Data Requirement and Design. The issue body's two TBD sections are gone, replaced by a resolved Data Requirement (traced to D1, decided 2026-07-19) and a Design section linking the new 35_design.html β ten sections, D1βD3 recorded as settled and D4βD9 opened for sign-off (stage-zone ladder, the β₯4 mg/dL rule as a mark, negative deltas, baseline resolution, which demo dataset, eGFR derivation). Business Requirement, Overview, and Tasks were left untouched; nothing was deleted, and goal #78 was never edited. A review-gate comment carries the four findings and the six-decision table.
The finding that reshapes the requirement: the current demo data cannot demonstrate this chart. Measured from safety.viz/site/data/adbds.csv β max creatinine fold change 1.455Γ, zero participants at or above the 1.5Γ KDIGO Stage-1 line, 9 above the 0.3 mg/dL cut, every value in Β΅mol/L. The scatter would render an all-white-zone blob. I recomputed this independently from the sibling's analysis and got the same numbers, which matters because it is the input to D8. The proposed fix is the RhoInc renderer-specific set rebuilt from its upstream source (RhoInc/data-library, MIT) rather than restoring safety.viz's old vendored copy: upstream populates all four fold stages (73/24/10/3 over 110 participants) and carries AGE and DY, which the vendored copy dropped.
Two more measured findings, neither derivable by reading the source. The RhoInc set's kidney measures are mutually independent β creatinine vs eGFR r=0.005, cystatin C vs eGFRcys r=β0.023, creatinine vs cystatin C r=β0.054 β so its shipped eGFR columns are not a function of its creatinine, and the unit column labels a filtration rate ΞΌmol/L; medians look right, so only per-record checking catches it. Phase 1 is unaffected (creatinine only), but Phase 2 must derive eGFR rather than ship those columns. And the DELTA_STAGE trap flagged in #35 turns out to have a sharper shape than "Stage 2/3 unreachable": the ggplot stage rectangles are painted descending while the case_when is ascending, so the shipped app plots a 2.0 mg/dL participant inside the Stage-2 zone and labels them "Stage 1" in the table beside it β chart right, table wrong.
A safety.viz Phase-1 implementation issue is drafted but deliberately not posted (.github/drafts/safety.viz/ISSUE_N_nep-phase1.md, 8 NEP-* scope items plus a "do not port these" section). Three of the six open decisions change its scope, so posting it before sign-off would file a scoping error.
Two scaffold findings became issues. obot.agent#57: sibling heartbeat lines land at the end of the scratchpad β under ## Scaffold β because the session-spawn contract specifies appending via shell >>. This is the second occurrence (flagged at last night's wrapup, unfixed), and today all six nep-design lines landed wrong; the file was repaired by hand before the report froze it. obot.agent#58: the merge-gate-guard hook matches its trigger phrase anywhere in a Bash command string, so it blocked a spawn whose briefing text merely described the merge policy β no merge was attempted.
9d4a4af (design doc) and 84f00a8 (two wording corrections), both as obotclaw[bot]; deploy green.9d4a4af sat ~15 minutes on r-lib/actions/setup-r@v2 (normal end-to-end is ~5.5 min), blocking the queued run behind it. Cancelling was safe β the upload and deploy steps had not started, so the live site was never partial β and the newer run for 84f00a8 published the corrected text. Worth watching: if setup-r hangs again, it is an infrastructure problem, not a one-off. The bot token cannot cancel runs (403, no Actions write scope); a user token was needed.auto, autonomous-eligible).draft label is likewise still on.--auto diary.This entry was drafted by Claude Code using Fable 5 in an unattended --auto session.